HCW Biologics (NASDAQ:HCWB) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $(0.44) by 184.09 percent. This is a 840 percent increase over losses of $(0.05) per share from the same period last year. The company reported $6.543 million in sales this quarter. This is a 129.08K percent increase over sales of $5.065 thousand the same period last year.